Colorado Capital Management’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,278
| Closed | -$16K | – | 80 |
|
|
2023
Q3 | $16K | Hold |
2,278
| – | – | 0.01% | 80 |
|
|
2023
Q2 | $12K | Hold |
2,278
| – | – | 0.01% | 76 |
|
|
2023
Q1 | $7K | Sell |
2,278
-2,277
| -50% | -$7K | 0.01% | 77 |
|
|
2022
Q4 | $18K | Buy |
4,555
+2,727
| +149% | +$10.8K | 0.02% | 75 |
|
|
2022
Q3 | $7K | Hold |
1,828
| – | – | 0.01% | 72 |
|
|
2022
Q2 | $24K | Hold |
1,828
| – | – | 0.02% | 79 |
|
|
2022
Q1 | $9K | Hold |
1,828
| – | – | 0.01% | 78 |
|
|
2021
Q4 | $12K | Hold |
1,828
| – | – | 0.01% | 79 |
|
|
2021
Q3 | $56K | Hold |
1,828
| – | – | 0.04% | 72 |
|
|
2021
Q2 | $59K | Hold |
1,828
| – | – | 0.04% | 74 |
|
|
2021
Q1 | $69K | Hold |
1,828
| – | – | 0.05% | 73 |
|
|
2020
Q4 | $87K | Hold |
1,828
| – | – | 0.06% | 73 |
|
|
2020
Q3 | $59K | Hold |
1,828
| – | – | 0.05% | 69 |
|
|
2020
Q2 | $80K | Hold |
1,828
| – | – | 0.07% | 73 |
|
|
2020
Q1 | $59K | Buy |
+1,828
| New | +$59K | 0.05% | 74 |
|
|
2017
Q1 | – | Sell |
-697
| Closed | -$50K | – | 71 |
|
|
2016
Q4 | $50K | Hold |
697
| – | – | 0.05% | 66 |
|
|
2016
Q3 | $95K | Hold |
697
| – | – | 0.09% | 63 |
|
|
2016
Q2 | $120K | Hold |
697
| – | – | 0.12% | 61 |
|
|
2016
Q1 | $131K | Hold |
697
| – | – | 0.13% | 64 |
|
|
2015
Q4 | $245K | Buy |
+697
| New | +$245K | 0.27% | 55 |
|